Eli Lilly

Lilly Covid-19 Trial Halted on Safety Concern

US medical research agency the National Institutes of Health (NIH) has paused a Phase 3 study on Eli Lilly’s Covid-19 antibody treatment on a potential safety concern.

Topics • Strategy

Continuous Pharmaceutical Manufacturing

Topics • Technology

Technology and Innovation in the Pharmaceutical Industry

Eli Lilly in Immunology Pact with Sitryx

Lilly to Build Injectables Plant in North Carolina

Lilly Boosts Dermatology with Dermira Buy

US to Allow Drug Reimports from Canada

Lilly in $400 Million Expansion at Indianapolis

Bayer Animal Health and VLPbio to Collaborate

Topics • Strategy

Injecting Growth and Innovation

Topics • Strategy

Continuous Processing

Lilly Wins Alimta Appeal

Bayer and Elanco Animal Health Link-up?

Lilly and Avidity Biosciences Partner on New Drugs

Topics • Strategy

The Need for Innovation in Pharmaceutical Manufacturing

Lilly Launches cut-price Generic Insulin in US

Eli Lilly to Buy Loxo for $8 Billion

DCAT Announces New Board of Directors

Lilly and Chugai in Diabetes Drug Pact

Eli Lilly Plans IPO for Elanco

Eli Lilly to Buy AurKa Pharma and ARMO

Ex-Lilly Executive Confirmed as US Health Secretary

US Health Secretary Pick Hammered on Price Gouging

Former Lilly President to Head US Health Department

FDA Approves Lilly Breast Cancer Drug

Lilly and CureVac in Cancer Vaccines Pact

Lilly to cut 3,500 jobs by Year-end

Eli Lilly and Nektar Develop Autoimmune Therapy

UK Supreme Court Upholds Lily Alimta Patent

Drug Patent Losses Worth Billions Seen in 2017

Pharma Chiefs Call for Decision on EMA

Lilly to Invest $850 Million in US Operations

FDA Approves Novartis Breast Cancer Drug

US Drugmakers Urge Tax Code Reform

Trump Discusses Issues With Drugmakers

99 more articles

Top-Feature

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

The UK Chemical Supply Chain

Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

SchüllerConsulting

Eli Lilly and Company

Oracle Germany

Sanofi S.A.

Lilly Deutschland GmbH

DCAT - Drug, Chemical & Associated Technologies Association

Camelot Management Consultants AG

Microinnova Engineering GmbH

IEDC Europe Indiana

Frost & Sullivan

Fitch Ratings

Isomorphic Labs

GlaxoSmithKline (GSK) plc

CONTINUUS Pharmaceuticals, Inc.